======= ZMYM2 ======= == Gene Information == * **Official Symbol**: ZMYM2 * **Official Name**: zinc finger MYM-type containing 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7750|7750]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UBW7|Q9UBW7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZMYM2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZMYM2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602221|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a zinc finger protein that may act as a transcription factor. The encoded protein may be part of a BHC histone deacetylase complex. Translocation of this gene with the fibroblast growth factor receptor-1 gene (FGFR1) results in a fusion gene, which may be a cause of stem cell leukemia lymphoma syndrome (SCLL). Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010]. * **UniProt Summary**: N/A |DUF3504| |zf-FCS| |ubiquitin conjugating enzyme binding| |PML body| |regulation of cell morphogenesis| |zinc ion binding| |regulation of anatomical structure morphogenesis| |DNA-binding transcription factor activity, RNA polymerase II-specific| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-2.46| |[[:results:exp336|Asunaprenir 3μM R07 exp336]]|-2.44| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|-2.26| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|-2.24| |[[:results:exp210|LB-100 2μM R05 exp210]]|-2.2| |[[:results:exp471|Cholesterol 0.003 to 0.006 to 0.1μM on day2 then day6 R08 exp471]]|-2.16| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|-2.04| |[[:results:exp504|MK2206 4μM R08 exp504]]|-1.99| |[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|-1.92| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|-1.91| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-1.9| |[[:results:exp375|Lenalidomide 20μM R07 exp375]]|-1.86| |[[:results:exp209|Deguelin 0.15μM R05 exp209]]|-1.83| |[[:results:exp405|Tenofovir 10μM R07 exp405]]|-1.82| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|-1.8| |[[:results:exp281|Disulfiram 4.3μM R06 exp281]]|-1.76| |[[:results:exp144|PFI-3 10μM R03 exp144]]|-1.75| |[[:results:exp423|Zebularine 20μM R07 exp423]]|-1.73| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|1.78| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|1.79| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|1.82| |[[:results:exp67|BVD-523 15μM R02 exp67]]|1.9| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|1.92| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|2.05| |[[:results:exp59|UMK57 1μM R01 exp59]]|2.2| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|2.45| ^Gene^Correlation^ |[[:human genes:a:asb7|ASB7]]|0.529| |[[:human genes:i:id3|ID3]]|0.527| |[[:human genes:s:ssbp2|SSBP2]]|0.498| |[[:human genes:a:asxl2|ASXL2]]|0.481| |[[:human genes:n:nsd1|NSD1]]|0.462| |[[:human genes:m:maml1|MAML1]]|0.453| |[[:human genes:c:cbx3|CBX3]]|0.451| |[[:human genes:b:bap1|BAP1]]|0.434| |[[:human genes:c:cbfb|CBFB]]|0.428| |[[:human genes:z:znf706|ZNF706]]|0.42| |[[:human genes:r:runx1|RUNX1]]|0.417| |[[:human genes:t:trim33|TRIM33]]|0.415| |[[:human genes:m:mef2c|MEF2C]]|0.411| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7646 * **Expression level (log2 read counts)**: 7.11 {{:chemogenomics:nalm6 dist.png?nolink |}}